The decision may have been made to avoid regulation by the FDA, according to BuzzFeed.
"Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.
'I don’t think Apple wants to be a health-monitoring device maker,' said Harry Wang, director of health and mobile product research at Parks Associates. 'They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.'"
From the article "The Apple Watch Is Scaling Back Its Health Features" by Ian Servantes.
Parks Associates, a market intelligence firm, claims that while connectivity is still in its infancy, it is moving along rather quickly. “We’re moving past the early adopter phase of connected cars,”...
More than 25% of US smartphone owners make use of mobile payment apps at least once a month, research from Parks Associates reveals. “More than 3m retailers combined accept Apple Pay and Android Pay,...
This Editor was interested in what the organizers of the annual Connected Health Summit, now taking place in San Diego, are seeing as the differences in the digital health and remote monitoring sector...
Wireless data usage is growing steadily from 2015 to 2016 as consumers shift data-heavy activities from desktop to mobile. According to Parks Associates’ latest survey data, average monthly wireless d...
